August 09, 2021
Video
The executive director of Banner Alzheimer’s Institute discussed the approval of aducanumab and the potential to address unmet needs and gaps in care for patients with Alzheimer disease.
August 09, 2021
Video
The approval of aducanumab and other advancements in Alzheimer disease diagnosis remain at the forefront of discussion; Eric Reiman, MD, spoke on the state of diagnosis and those ongoing conversations.
August 08, 2021
Video
The executive director of Banner Alzheimer’s Institute discussed the future of blood tests as a biomarker that may help in addressing current challenges, including drug development.
August 06, 2021
Video
The executive director of Banner Alzheimer’s Institute commented on ongoing research into amyloid plaque-reducing antibody therapies, the approval of aducanumab, and other initiatives with the ability to impact the treatment of Alzheimer disease.
August 05, 2021
Video
The executive director of Banner Alzheimer’s Institute discussed the current state of AD trials, as well as his perspective on ongoing efforts to establish prevention therapies.
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine
Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD
Periconceptional Folic Acid Supplementation Decreases Risk of Preterm Birth in Epilepsy
Changing the Future of Stroke Care: The 2021 ASA/AHA Prevention Guidelines